Dengue - opportunities for diagnostics companies
This article was originally published in Clinica
Executive Summary
The proliferation of dengue fever across the world's tropical latitudes and beyond the borders of endemic countries, has put the disease high on the global diagnostics agenda. Considerations that emerge from an assessment of the technologies available to diagnose the disease and the typical market dynamics that dictate their use, have wider implications for other population-wide screening technologies. Latin America is host to the current epidemic, writes Bernard Murphy.